Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy

Yujie Wang,Tingting Deng,Xi Liu,Xueyang Fang,Yongpan Mo,Ni Xie,Guohui Nie,Bin Zhang,Xiaoqin Fan

DOI: https://doi.org/10.2147/ijn.s459710

IF: 7.033

2024-06-20

International Journal of Nanomedicine

Abstract:Yujie Wang, 1 Tingting Deng, 1 Xi Liu, 2 Xueyang Fang, 1 Yongpan Mo, 3 Ni Xie, 4 Guohui Nie, 1 Bin Zhang, 1 Xiaoqin Fan 1, 4 1 Shenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Department of Otolaryngology, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, People's Republic of China; 2 Department of Nephrology, Shenzhen Longgang Central Hospital, Shenzhen, 518116, People's Republic of China; 3 Department of Breast Surgery, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, 518035, People's Republic of China; 4 The Bio-Bank of Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, Guangdong, 518035, People's Republic of China Correspondence: Bin Zhang; Xiaoqin Fan, Email ; The tumor microenvironment (TME) is a complex and dynamic entity, comprising stromal cells, immune cells, blood vessels and extracellular matrix, which is intimately associated with the occurrence and development of cancers, as well as their therapy. Utilizing the shared characteristics of tumors, such as an acidic environment, enzymes and hypoxia, researchers have developed a promising cancer therapy strategy known as responsive release of nano-loaded drugs, specifically targeted at tumor tissues or cells. In this comprehensive review, we provide an in-depth overview of the current fundamentals and state-of-the-art intelligent strategies of TME-responsive nanoplatforms, which include acidic pH, high GSH levels, high-level adenosine triphosphate, overexpressed enzymes, hypoxia and reductive environment. Additionally, we showcase the latest advancements in TME-responsive nanoparticles. In conclusion, we thoroughly examine the immediate challenges and prospects of TME-responsive nanopharmaceuticals, with the expectation that the progress of these targeted nanoformulations will enable the exploitation, overcoming or modulation of the TME, ultimately leading to significantly more effective cancer therapy. Keywords: tumor microenvironment, stimulus-responsive, drug delivery, cancer therapy, intelligent biomedicine Graphical Malignant tumors are a leading cause of human mortality. In recent years, significant advancements have been made in tumor therapy, thanks to the development of various approaches. Notably, nanotechnology and targeted drug delivery systems have garnered considerable attention due to the favorable characteristics of nanoparticles, such as excellent permeability, enhanced loading capacity and high specificity. Consequently, nanoparticles have become widely adopted as effective carriers for delivering chemotherapeutic drugs, nucleic acids and genes to precise target sites for the treatment of oncological diseases. The tumor microenvironment (TME) plays a pivotal role in tumor development, consisting of tumor cells, tumor stromal cells, the extracellular matrix, as well as various cytokines and chemokines (Figure 1). 1– 5 Compared to the normal human internal environment, the TME exhibits distinct biochemical properties, including hypoxia, acidity, strong redox characteristics, abnormal enzyme metabolism, and immunosuppression. 6 Of particular interest in recent research on nano-targeted agents are the weak acidic and strong redox properties, given their significant roles in tumor progression, metastasis and immune evasion. 7 Metabolic differences between cancer cells and normal cells contribute to unique features within the tumor microenvironment, such as hypoxia, angiogenesis, acidosis, hypermetabolism and elevated redox state. Customizing nanomaterials that target the tumor microenvironment based on its specific characteristics holds paramount importance. These tailored nanocarriers can facilitate tumor stimulus-responsive drug delivery through size adjustments, surface charge conversion or other modifications of physicochemical properties. This adaptability ensures that the nanomaterials possess the necessary attributes for efficient accumulation in tumor tissues, penetration into tumor cells, facilitation of endocytosis and ultimately, controlled drug release. Figure 1 Composition and features of the tumor microenvironment (TME). The TME comprises various components, including endothelial cells, pericytes, immune cells, cancer-associated fibroblasts (CAFs), cancer stem cells (CSCs), extracellular matrix (ECM), blood vessels and other elements present in this complex biological environment. It significantly differs from the normal cellular microenvironment -Abstract Truncated-

pharmacology & pharmacy,nanoscience & nanotechnology